BACKGROUND: Emerging evidence has suggested a contribution of bone marrow (BM) cells to lymphatic vessel formation; however, the exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be identified. Here, we investigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic neovascularization. METHODS AND RESULTS: Culture of BM-mononuclear cells in the presence of vascular endothelial growth factors A and C and endothelial growth factor resulted in expression of lymphatic endothelial cell markers. Among these cells, podoplanin(+) cells were isolated by magnetic-activated cell sorting and characterized by fluorescence-activated cell sorter analysis and immunocytochemistry. These podoplanin(+) cells highly express markers for lymphatic endothelial cells, hematopoietic lineages, and stem/progenitor cells; on further cultivation, they generate lymphatic endothelial cells. We further confirmed that podoplanin(+) cells exist in small numbers in BM and peripheral blood of normal mice but are significantly (15-fold) augmented on lymphangiogenic stimuli such as tumor implantation. Next, to evaluate the potential of podoplanin(+) cells for the formation of new lymphatic vessels in vivo, we injected culture-isolated or freshly isolated BM-derived podoplanin(+) cells into wound and tumor models. Immunohistochemistry demonstrated that the injected cells were incorporated into the lymphatic vasculature, displayed lymphatic endothelial cell phenotypes, and increased lymphatic vascular density in tissues, suggesting lymphvasculogenesis. Podoplanin(+) cells also expressed high levels of lymphangiogenic cytokines and increased proliferation of lymphatic endothelial cells during coculture, suggesting a lymphangiogenic or paracrine role. CONCLUSIONS: Our results provide compelling evidence that BM-derived podoplanin(+) cells, a previously unrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnatal lymphatic neovascularization through both lymphvasculogenesis and lymphangiogenesis.
BACKGROUND: Emerging evidence has suggested a contribution of bone marrow (BM) cells to lymphatic vessel formation; however, the exact phenotype of the cells with lymphatic endothelial progenitor cell function has yet to be identified. Here, we investigate the identity of BM-derived lymphatic endothelial progenitor cells and their role in lymphatic neovascularization. METHODS AND RESULTS: Culture of BM-mononuclear cells in the presence of vascular endothelial growth factors A and C and endothelial growth factor resulted in expression of lymphatic endothelial cell markers. Among these cells, podoplanin(+) cells were isolated by magnetic-activated cell sorting and characterized by fluorescence-activated cell sorter analysis and immunocytochemistry. These podoplanin(+) cells highly express markers for lymphatic endothelial cells, hematopoietic lineages, and stem/progenitor cells; on further cultivation, they generate lymphatic endothelial cells. We further confirmed that podoplanin(+) cells exist in small numbers in BM and peripheral blood of normal mice but are significantly (15-fold) augmented on lymphangiogenic stimuli such as tumor implantation. Next, to evaluate the potential of podoplanin(+) cells for the formation of new lymphatic vessels in vivo, we injected culture-isolated or freshly isolated BM-derived podoplanin(+) cells into wound and tumor models. Immunohistochemistry demonstrated that the injected cells were incorporated into the lymphatic vasculature, displayed lymphatic endothelial cell phenotypes, and increased lymphatic vascular density in tissues, suggesting lymphvasculogenesis. Podoplanin(+) cells also expressed high levels of lymphangiogenic cytokines and increased proliferation of lymphatic endothelial cells during coculture, suggesting a lymphangiogenic or paracrine role. CONCLUSIONS: Our results provide compelling evidence that BM-derived podoplanin(+) cells, a previously unrecognized cell type, function as lymphatic endothelial progenitor cells and participate in postnatal lymphatic neovascularization through both lymphvasculogenesis and lymphangiogenesis.
Authors: Levi G Ledgerwood; Girdhari Lal; Nan Zhang; Alexandre Garin; Steven J Esses; Florent Ginhoux; Miriam Merad; Helene Peche; Sergio A Lira; Yaozhong Ding; Yu Yang; Xingxuan He; Edward H Schuchman; Maria L Allende; Jordi C Ochando; Jonathan S Bromberg Journal: Nat Immunol Date: 2007-11-25 Impact factor: 25.606
Authors: Dontscho Kerjaschki; Nicole Huttary; Ingrid Raab; Heinz Regele; Katalin Bojarski-Nagy; Gregor Bartel; Stefan M Kröber; Hildegard Greinix; Agathe Rosenmaier; Franz Karlhofer; Nikolaus Wick; Peter R Mazal Journal: Nat Med Date: 2006-01-15 Impact factor: 53.440
Authors: Renhai Cao; Meit A Björndahl; Marta I Gallego; Shaohua Chen; Piotr Religa; Anker J Hansen; Yihai Cao Journal: Blood Date: 2006-01-19 Impact factor: 22.113
Authors: K Schledzewski; M Falkowski; G Moldenhauer; P Metharom; J Kzhyshkowska; R Ganss; A Demory; B Falkowska-Hansen; H Kurzen; S Ugurel; G Geginat; B Arnold; S Goerdt Journal: J Pathol Date: 2006-05 Impact factor: 7.996
Authors: Kazuichi Maruyama; Jun Asai; Masaaki Ii; Tina Thorne; Douglas W Losordo; Patricia A D'Amore Journal: Am J Pathol Date: 2007-04 Impact factor: 4.307
Authors: David Olmeda; Gema Moreno-Bueno; Juana M Flores; Angels Fabra; Francisco Portillo; Amparo Cano Journal: Cancer Res Date: 2007-12-15 Impact factor: 12.701
Authors: Lisa Volk-Draper; Radhika Patel; Nihit Bhattarai; Jie Yang; Andrew Wilber; David DeNardo; Sophia Ran Journal: Am J Pathol Date: 2019-08-15 Impact factor: 4.307
Authors: Jason C Gardenier; Geoffrey E Hespe; Raghu P Kataru; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Joseph J Dayan; David Chang; Jamie Zampell; Inés Martínez-Corral; Sagrario Ortega; Babak J Mehrara Journal: JCI Insight Date: 2016-09-22
Authors: Wensheng Wang; Xi Lin; Hao Xu; Wen Sun; Echoe M Bouta; Michael J Zuscik; Di Chen; Edward M Schwarz; Lianping Xing Journal: Arthritis Rheumatol Date: 2019-01-05 Impact factor: 10.995
Authors: Felix Becker; Emily Romero; Jason Goetzmann; Dana L Hasselschwert; Beth Dray; John Vanchiere; Jane Fontenot; J Winny Yun; Paul C Norris; Luke White; Melany Musso; Charles N Serhan; J Steven Alexander; Felicity N E Gavins Journal: Am J Pathol Date: 2019-10 Impact factor: 4.307